Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
Showing 1 - 25 of >10,000
Pre-Exposure Prophylaxis of HIV Infection Trial (Lenacapavir Injection, Lenacapavir Tablet, Emtricitabine/tenofovir disoproxil
Not yet recruiting
- Pre-Exposure Prophylaxis of HIV Infection
- Lenacapavir Injection
- +2 more
- (no location specified)
Oct 20, 2023
Pre-Exposure Prophylaxis of HIV Infection Trial (Lenacapavir Tablet, Lenacapavir Injection, Emtricitabine/Tenofovir Disoproxil
Not yet recruiting
- Pre-Exposure Prophylaxis of HIV Infection
- Lenacapavir Tablet
- +2 more
- (no location specified)
Oct 20, 2023
Bone Mineral Density Substudy - An Ancillary Study to MTN-003
Completed
- HIV Infections
- Emtricitabine/tenofovir disoproxil fumarate
- +3 more
-
Kampala, Uganda
- +3 more
Oct 28, 2021
HIV Trial (Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC), cabotegravir (CAB-LA), Cabotegravir (CAB-LA), Tenofovir
Not yet recruiting
- HIV
- Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC), cabotegravir (CAB-LA)
- Cabotegravir (CAB-LA), Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC)
- (no location specified)
Nov 13, 2023
Acceptability of Health Care, Adherence, Medication Trial in Durban, Pietermaritzburg, Harare (emtricitabine/tenofovir
Recruiting
- Acceptability of Health Care
- Adherence, Medication
- emtricitabine/tenofovir alafenamide
- Emtricitabine / Tenofovir Disoproxil Oral Tablet
-
Durban, KZN, South Africa
- +2 more
Jul 12, 2022
Drug Interaction Trial in Bangkok (Emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg (F/TDF) and emtricitabine 200
Recruiting
- Drug Interaction
- Emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg (F/TDF) and emtricitabine 200 mg/tenofovir alafenamide 25 mg (F/TAF)
-
Bangkok, Pathumwan, ThailandInstitute of HIV Research and Innovation (IHRI)
Apr 21, 2022
Pregnancy, HIV-1-infection Trial (Standard dose Truvada®, Pregnancy-adjusted dose Truvada®)
Withdrawn
- Pregnancy
- HIV-1-infection
- Standard dose Truvada®
- Pregnancy-adjusted dose Truvada®
- (no location specified)
Mar 28, 2022
HIV-1/HBV Co-Infection Trial in Worldwide (B/F/TAF, Placebo to match DTG, Placebo to match F/TDF)
Active, not recruiting
- HIV-1/HBV Co-Infection
- B/F/TAF
- +5 more
-
Fort Pierce, Florida
- +66 more
Sep 19, 2022
HIV Trial in Worldwide (Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF), Behavioral HIV risk reduction package)
Recruiting
- HIV Infections
- Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF)
- Behavioral HIV risk reduction package
-
Blantyre, Malawi
- +6 more
Jun 20, 2022
HIV/AIDS, Adherence, Medication, Drug Use Trial in Norfolk (Tenofovir Disoproxil Fumarate)
Completed
- HIV/AIDS
- +2 more
- Tenofovir Disoproxil Fumarate
-
Norfolk, VirginiaClinical Research Center, Eastern Virginia Medical School
Apr 12, 2022
HIV Trial in Johannesburg, Kampala, Chitungwiza (Dapivirine (DPV) Vaginal Ring (VR)-004, Truvada Tablet)
Completed
- HIV Infections
- Dapivirine (DPV) Vaginal Ring (VR)-004
- Truvada Tablet
-
Blantyre, Malawi
- +3 more
Nov 17, 2022
HIV-1-infection Trial in Edmonton (B/F/TAF, Atripla, B/F/TAF Placebo)
Terminated
- HIV-1-infection
- B/F/TAF
- +3 more
-
Edmonton, Alberta, CanadaUniversity of Alberta
Nov 21, 2022
HIV-1-infection Trial in Shanghai, Kunming, Hangzhou (B/F/TAF, TDF-based triple ART regimen switching to B/F/TAF)
Recruiting
- HIV-1-infection
- B/F/TAF
- TDF-based triple ART regimen switching to B/F/TAF
-
Shanghai, Shanghai, China
- +2 more
Dec 1, 2022
Aicardi Goutières Syndrome Trial in Philadelphia (Tenofovir (TDF) and Emtricitabine (FTC), Placebo)
Not yet recruiting
- Aicardi Goutières Syndrome
- Tenofovir (TDF) and Emtricitabine (FTC)
- Placebo
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Feb 8, 2022
HIV Pre-exposure Prophylaxis During Breastfeeding Trial in Thika, Kampala (FTC/TDF PrEP)
Completed
- HIV Pre-exposure Prophylaxis During Breastfeeding
- FTC/TDF PrEP
-
Thika, Kenya
- +1 more
Sep 14, 2021
Drug Interaction Trial in Montréal (ATI-2173 50 mg, Tenofovir 300Mg Oral Tablet)
Completed
- Drug Interaction
- ATI-2173 50 mg
- Tenofovir 300Mg Oral Tablet
-
Montréal, Quebec, CanadaAltasciences
Feb 3, 2022
HIV Trial in Johannesburg (Cabotegravir Injection [Apretude], Tenofovir disoproxil fumarate / emtricitabine (or lamivudine))
Not yet recruiting
- HIV Infections
- Cabotegravir Injection [Apretude]
- Tenofovir disoproxil fumarate / emtricitabine (or lamivudine)
-
Johannesburg, Gauteng, South AfricaEzintsha, a division of Wits Health Consortium
Nov 13, 2023
HIV Trial in Johannesburg, Kampala, Chitungwiza (Dapivirine (DPV) Vaginal Ring (VR), Truvada Tablet)
Active, not recruiting
- HIV Infections
- Dapivirine (DPV) Vaginal Ring (VR)
- Truvada Tablet
-
Blantyre, Malawi
- +3 more
Feb 1, 2023
Hepatitis B, Chronic, Hepatitis D Trial in Chisinau, Kyiv (ATI-2173, Viread, AB-729)
Terminated
- Hepatitis B, Chronic
- Hepatitis D
- ATI-2173
- +2 more
-
Chisinau, Republic Of Moldova, Moldova, Republic of
- +1 more
Nov 15, 2022
HIV Trial (Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg)
Completed
- HIV Infections
- Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg
- (no location specified)
May 11, 2022
Multiple Sclerosis Trial in Boston (Truvada (tenofovir/emtricitabine))
Enrolling by invitation
- Multiple Sclerosis
- Truvada (tenofovir/emtricitabine)
-
Boston, MassachusettsMassachusetts General Hospital
Jul 14, 2023
Antiretroviral Adherence and Drug-level Monitoring
Recruiting
- HIV Infections
- +4 more
-
Surabaya, East Java, IndonesiaUniversitas Airlangga Hospital
Aug 17, 2023
Medication Adherence, HIV Trial in Pittsburgh (dolutegravir oral tablet 50mg, emtricitabine/tenofovir alafenamide oral tablet
Completed
- Medication Adherence
- HIV
- dolutegravir oral tablet 50mg
- +3 more
-
Pittsburgh, PennsylvaniaHIV/AIDS Clinical Research Unit / University of Pittsburgh
Mar 2, 2022